Clinical Trials Directory

Trials / Completed

CompletedNCT01295281

Evaluation of a New Catheter Material for Intermittent Catheterization

A Prospective, Randomized, Cross-over Study - Evaluation of a New Catheter Material for Intermittent Catheterization

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
Wellspect HealthCare · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The hypothesis to be investigated is if the tolerability of intermittent catheterization with Polyolefin Based Elastomer (POBE) 2.0 and Polyvinyl Chloride (PVC) is clinically equal - i.e. clinically non-inferior when using POBE 2.0 compared to PVC. Secondary objectives are to evaluate the safety and the subject's perception associated with the use of the catheters, assessed by the recording of adverse events and the ease of handling by means of a subjective assessment scale.

Conditions

Interventions

TypeNameDescription
DEVICELoFric POBE 2.0To be used at least twice daily, during 7 days. Treatment period 1 and 2 last 7 days, respectively.
DEVICELoFric PVCTo be used at least twice daily, during 7 days. Treatment period 1 and 2 last 7 days, respectively.

Timeline

Start date
2011-03-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2011-02-14
Last updated
2021-11-11
Results posted
2014-03-03

Locations

6 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01295281. Inclusion in this directory is not an endorsement.

Evaluation of a New Catheter Material for Intermittent Catheterization (NCT01295281) · Clinical Trials Directory